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ABSTRACT 
INTRODUCTION: 
Swellings of the parotid gland are of special interest to a surgeon’s keen eye. 
These lesions are not only involved in diseases isolated to the parotid but can also 
present as a part of a generalized systemic disorder, medical or surgical. For a 
surgeon the interests lie in the probable origin of the swelling, its involvement of 
the facial nerve, the variability in behavior, regarding the operability criteria and its 
post-operative complications. A comprehensive knowledge of the anatomy of the 
parotid and the prediction of the swelling behaviour can help not only in the 
diagnosis but also in ensuring an apt management of the lesion and the patient. 
AIMS: 
This cohort study was conducted to analyse the following  in our institution 
1. The incidence of various of parotid swellings. 
2. To discuss accuracy of FNAC in comparison to the histo-pathological 
reports.  
3.  The various surgical modalities of treatment of parotid swellings applied . 
4. To discuss the post-operative complications.  
5. To compare findings of the above study with world statistics.  
 
MATERIALS AND METHODS: 
The cohort study which included 45 patients was conducted at Kilpauk 
medical college hospital and Government Royapettah Hospital from September 
2010 to October 2012. Data was collected from the patients after obtaining an 
informed consent. The demographic details of the patients and history of their 
swelling was taken. The patients were examined and basic investigations 
performed. Details regarding the FNAC report, surgical and non-surgical 
management were noted. Post-operative complications were documented. The final 
histopathological report was analysed and compared with the FNAC report. 
Inclusion criteria  were patients with parotid swellings neoplastic and non-
neoplastic and those above 12years of age. Exclusion criteria were patients with 
parotid lesions due to systemic or metabolic illness and those with age less than 12 
years.  
CONCLUSION: 
The analysis of the data of the study conducted at our institution provided us 
with the following results: 
1. Parotid lesions comprised of the most common salivary gland lesions in our 
hospital. 
2. Amongst the various lesions it was noted that benign tumours were the most 
common and the least common were non-neoplastic disorders. 
3. The sex incidence showed a similar distribution among both males and females 
with the ratio being 1:1.25. 
4. The mean age of presentation was 49 yearsand it was seen that the 4th and 7th 
decades where the predominant age group for occurrence in case of benign and 
malignant tumours respectively. 
5. The lesions which were predominant in the non-neoplastic, benign and 
malignant tumours groups where abscess, pleomorphic adenoma and 
mucoepidermoid carcinomas respectively. These were found to be consistent 
with the comparison made with world statistics.  
6. FNAC correlated in a total of 39 out of 45 cases, i.e.86.67% of the cases. 
The sensitivity and specificity for detection of benign tumors was found to be 
93.75% and 100% respectively. In the case of malignant tumours the 
sensitivity and specificity was found to be 87.5% and 100% respectively.  
 
7. Patients presenting with facial nerve palsy was seen more amid the malignant 
tumors. 
8. Most commonly performed surgery was superficial parotidectomy. Completion 
parotidectomy was performed in 2 cases and both were malignant tumors with 
recurrence. 
9. Facial nerve palsy and seroma formation were the commonest complication 
noted post-operatively.  
10. Radiotherapy was the most common non-surgical modality used and 
administered more commonly post-operatively. 
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INTRODUCTION 
Swellings of the parotid gland are of special interest to a surgeon’s 
keen eye. These lesions are not only involved in diseases isolated to the 
parotid but can also present as a part of a generalized systemic disorder, 
medical or surgical. The patient would present invariably due to the 
cosmetic problem. For a surgeon the interests lie in the probable origin of 
the swelling, its involvement of the facial nerve, the variability in 
behavior, regarding the operability criteria and its post-operative 
complications. Patients in these cases present themselves to oncologists 
and general surgeons alike for the same. A comprehensive knowledge of 
the anatomy of the parotid and the prediction of the swelling behaviour 
can help not only in the diagnosis but also in ensuring an apt management 
of the lesion and the patient. 
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REVIEW OF LITERATURE 
"It follows from the complex relations of the parotid that its entire 
removal as a surgical procedure is an anatomical impossibility."  
Sir Frederick Treves, Surgical anatomist 
The parotid gland derives its name from the Greek word meaning 
“para auricular” swelling.  Surgical treatment of parotid tumors has been 
greatly influenced by the intimate relationship of the facial nerve to the 
gland. The intricacy of its anatomy to the neuro-vascular structures has 
plagued anatomists and surgeons alike for years. McWhorter
13
 considered 
that the gland was divided into two lobes, with an interconnecting 
isthmus and the facial nerve passing around the isthmus and between the 
two lobes. The consensus has changed over the years to believe that the 
gland actually is divided into deep and superficial portions due to the 
emergence of the facial nerve. The parotid duct was discovered in 1660 
by Niels Stensen and hence named after him
1
. The first clinical 
description of a parotid tumour was given in 1752 by Kaltshmeid, 
whereas a classification of tumors was given by Berard in 1841. For 
several years the parotid gland surgeries were performed with dismal 
results with respect to the facial nerve preservation. In 1892, the first 
attempt at total parotidectomy with facial nerve preservation was done by 
Codreanu 
1
. It was Blair in 1912 with careful dissection observing keenly 
for facial twitching while stimulating the nerve fibres devised the 
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technique for tumor removal with nerve preservation. But it was Sistrunk 
in 1921 who stressed the importance of exposure of the facial nerve while 
dissection of the gland
1
. It has been seen with several studies the 
commonest lesions affecting the parotid are the group of benign tumours. 
Incidence of non-neoplastic lesions has been found to be rarer in 
comparison, varying with studies and inflammatory disorders being the 
most common. A R Arshad, et al 
16
 have seen that the incidence of non-
neoplastic lesions was found to be around 11.8% where as Zbaren et al
15
 
have seen an incidence of 5.7%.  Pleomorphic adenoma has been seen to 
be the dominant lesion affecting the parotid. The treatment of 
pleomorphic adenoma has undergone a vast change from the initially 
performed enucleation of the tumour to the present concept of 
parotidectomy, superficial or total based on the depth of the tumors. 
Malignant parotid tumours are treated based on the lesion, its extent of 
involvement and attempts at preserving the facial nerve, unless it is 
involved, is the key concept at present. The concept of change to nerve 
preservation has brought down morbidity due to the nerve paralysis 
significantly improving on the cosmesis and quality of life of patients. An 
understanding of the cause-effect relationship of parotid tumours is still 
under research though many theories have been proposed regarding them.  
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EMBRYOLOGY:  
The development of the parotid gland is mostly seen around the 
sixth week of development, as an ectodermal derivative, when the 
formation of the duct occurs. It appears as an outgrowth from the oral 
epithelium and covers the first branchial arch’s maxillary process. It then 
grows posteriorly towards the ear and hence embedding the facial nerve 
along with its branches within the substance of the gland. There is then 
formation of canals from the solid cords and the differentiation of cells 
from the tips leads to formation of acini which are secretory in nature.  
 
Fig. a)  DEVELOPMENT OF PAROTID GLAND 
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ANATOMY: 
The parotid gland is the largest of the three salivary glands and is 
paired. It occupies the parotid region, named so due to the presence of the 
gland, which is present from below and front of the ear to below the 
zygomatic arch. It has the advantage of an irregular shape hence fitting 
snugly in the space provided for it. The gland is divided due to the 
presence of the facial nerve in to superficial (endo facial) and deep (exo 
facial) parts, around 80% of the gland being superficial. It shares its space 
in the compartment with the facial nerve and its branches, external carotid 
artery and its terminal branches, retro mandibular (posterior facial) vein 
and its divisions, lymph nodes and sensory and autonomic nerves.  The 
compartment boundaries comprise of the following: 
Anterior Border Diagonal line drawn from zygomatic root to the 
External auditory canal 
Posterior Border External auditory canal 
Superior border Zygoma. 
Inferior Border Styloid process, styloid process musculature, 
internal carotid artery, jugular veins 
 
The superficial part lies over the masseter and mandible, while the 
deep part or retro-mandibular portion extends through the 
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stylomandibular tunnel medially, which is in turn formed by posterior 
edge of the ramus(ventrally), anterior border of sternocleidomastoid and 
posterior belly of digastric (dorsally) and also the stylomandibular 
ligament deep dorsally. The stylomandibular ligament in fact separates 
the parotid and submandibular glands. The deep part of the gland is seen 
in the prestyloid compartment of the Parapharyngeal space and hence 
tumors in this portion of the gland can push the tonsillar fossa and soft 
palate medially in the intra-oral part. The gland is enclosed within a 
capsule continuous with the deep cervical fascia; the layer covering the 
superficial surface is dense and closely adherent to the gland forming the 
false capsule. A portion of the fascia, attached to the styloid process and 
the angle of the mandible, is thickened to form the stylomandibular 
ligament. True capsule is formed from condensation of the fibrous stroma 
of the gland. The superficial part is somewhat quadrilateral in shape, 
being broad above and tapering somewhat below 
Five processes have been described in the gland of which three are 
said to be superficial while two are deep. The superficial processes are: 
1. Condylar 2.Meatal 3. Posterior  
The deep processes are  
1. Glenoid  2. Stylomandibular 
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Due to the presence of multiple processes it is extremely difficult 
to ensure complete clearance of the gland during surgeries and this 
difficulty is increased due to the presence of the facial nerve.  
The gland has five surfaces, the apex, base or superior surface, 
superficial surface, anteromedial and posteromedial surfaces. 
The three borders of the gland are anterior, posterior and medial. 
Relations of the parotid: 
The antero-medial surface is molded on the posterior border of the 
ramus of the mandible and clothed by the medial pterygoid and masseter. 
The other anterior relations are the lateral surface of the temporo-
mandibiular joint and the emerging branches of the facial nerve. 
The postero-medial surface is grooved longitudinally and is seen to 
hitch against the external auditory meatus, the mastoid process and 
anterior border of sternomastoid. Thus its relations comprise of the 
mastoid process with the sternomastoid, posterior belly of digastric, 
styloid process and its attachments, external carotid artery which enters 
the gland through this surface. The internal carotid artery is deep to the 
styloid process in this part. 
The superficial surface slightly lobulated is covered by the 
integument, the superficial fascia containing the facial branches of the 
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great auricular nerve, platysma muscle and some small lymph glands, and 
the parotid fascia which forms the capsule of the gland. Parotid lymph 
nodes are embedded within the gland substance. 
The superior surface or the base is related to the cartilaginous 
portion of the external auditory meatus, temporo-mandibular joint, 
superficial temporal vessels and auriculo-temporal nerve. The auriculo-
temporal nerve winds around the neck of the mandible. 
The apex of the gland is seen to overlap the posterior belly of 
digastric and carotid triangle. Emerging from the apex are the two 
divisions of the retro-mandibular veins and the cervical branch of facial 
nerve. 
The borders of the gland are anterior, posterior and medial. The 
anterior border has the following structures emerging from it: the parotid 
duct, terminal branches of the facial nerve and transverse facial vessels.  
The medial border is present such that it separates the antero-medial and 
postero-medial surfaces. The posteromedial and superficial surfaces are 
separated by the posterior border. 
The process of the gland:  
Glenoid process is in the superior part of the gland extends 
upwards into the posterior mandibular fossa. The facial process is in the 
anterior margin of the gland extending forwards into the masseter. 
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The pterygoid process is seen between the medial pterygoid muscle 
and the mandibular ramus. 
Intra-glandular structures are( from medial to lateral): 
1. External carotid artery and its terminal branches 
2. Retromandibular vein 
3. Facial nerve and its terminal branches 
 The external carotid artery lies at first deep to the gland and then 
within the gland. In its substance it gives its two terminal branches, the 
internal maxillary and the superficial temporal arteries. The former runs 
forward deep to the neck of the mandible; the latter runs upward across 
the zygomatic arch and gives off its transverse facial branch which 
emerges from the front of the gland. 
Lateral to the artery the corresponding venous branches internal 
maxillary and superficial temporal unite to form the retro-mandibular 
vein (posterior facial vein). In the lower part of the gland this vein splits 
into anterior and posterior divisions. The anterior division emerges from 
the gland and unites with the anterior facial to form the common facial 
vein; the posterior unites in the gland with the posterior auricular to form 
the external jugular vein. 
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The most superficial of the structures is the facial nerve. The 
branches of which emerge from the borders of the gland. The course of 
the facial nerve after its exit from the stylomastoid foramen begins with 
branches being given off to the stylomastoid, posterior belly of digastric 
and posterior auricular muscles before its transition to formation of pes 
anserinus which occurs about 1cm anterior and 2 cm below the tragus. 
The facial nerve enters the gland from its postero-medial surface. It gives 
of its terminal branches from divisions: 
1. Temporo-facial – temporal, zygomatic and buccal branches 
2. Cervico-facial–marginal mandibular and cervical branches. 
The facial nerve and the retro-mandibular vein divide the gland into 
superficial and deep parts by the Facio-venous plane of Patey. Several 
studies regarding the facial nerve branching pattern have been done and 
the following conclusions were made
2, 3, 4
. 
Type I- No anastomosis occurred between branches of the facial 
nerve. 
Type II- Presence of an anastomotic connection between branches of 
temporo-facial division. 
Type III-A single anastomosis between the temporo-facial and 
cervico-facial divisions 
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Type IV- Combination of Type II and Type III. 
Type V- Two anastomotic rami passed from the cervico-facial 
division to intertwine with the branches of temporo-facial division. 
Type VI- Plexiform arrangement, the mandibular branch sends a 
twig to join any members of the temporo-facial division. 
Studies have shown variation in frequency of the type of facial nerve 
branching pattern. Weerapant et al
2
 compared their results with other 
groups and found that Type V was the most predominant while Type I 
was the least common. Others such as Davis et al
3
 showed that Type III 
was the most common type.  
Among the other nerves encountered in relation to the parotid the 
greater auricular nerve is the first to be encountered during raising of the 
skin flaps and is commonly sacrificed in surgery leading to anaesthesia of 
the region. The auriculo-temporal nerve is a branch or the trigeminal 
nerve and it relays post ganglionic parasympathetic secreto-motor fibres 
to the parotid to from the otic ganglion.  
The identification of facial nerve is of critical importance.  
The following are the important surgical landmarks for the same
5
: 
1. Tragal pointer- points to the main trunk of VII nerve proximal to 
the Pes and is 1–1.5 cm deep and below the pointer. 
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2. Tympano-mastoid suture – when traced medially the main trunk 
can be encountered 6–8 mm deep to the suture line. 
3. Posterior belly of digastric muscle – It is a guide to the stylo-
mastoid foramen; the trunk of the VII nerve is just superior and 
posterior to cephalic margin of the muscle. 
4. Styloid process- 5–8 mm deep to the Tympano-mastoid suture;  
trunk lies on the postero-lateral aspect of the Styloid near its base  
5. By retrograde  dissection one of the branches can be traced 
proximally 
a. Buccal branch- it runs with the parotid duct either superiorly or 
inferiorly. 
b. Temporal branch-  crosses the zygomatic arch parallel with the 
superficial temporal artery and vein  
c. Marginal Mandibular branch - runs along the inferior border of 
the parotid superficial to the retro-mandibular vein.  
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The Stylomastoid foramen is the single most constant landmark.  
 
Fig.b) IDENTIFICATION OF FACIAL NERVE INTRA-
OPERATIVELY WITH LANDMARKS 
 
Fig.c) STRUCTURES RELATED TO PAROTID GLAND ( 
SECTION TAKEN THROUGH THE GLAND) 
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Fig,d) ANATOMY OF PAROTID GLAND WITH FACIAL NERVE 
BRANCHES 
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Stenson’s duct: 
It arises from the anterior border of the parotid and parallels the 
zygomatic arch, around 1.5cm below the inferior margin. It runs 
superficial to the masseter muscle and turns medially 90 degrees to pierce 
the buccinator muscle at the level of the second maxillary molar where it 
opens onto the oral cavity. It measures approximately 4–6 cm in length 
and 5mm in diameter. The buccal branch of the VII nerve runs along with 
it. 
The Parotid is invested in its own fascia (capsule), which is 
continuous with the superficial layer of deep cervical fascia. The Parotid 
fascia consists of  
1) Superficial layer – extends from the masseter and 
Sternomastoid to the Zygoma, and  
2) Deep layer – extends from the fascia of the posterior belly of 
the Digastric muscle, and forms the Stylomandibular 
membrane separating the Parotid and Submandibular glands.  
The Parotid fascia sends septa into the glandular tissue, which 
prevents the possibility of separating the glandular tissue from its 
investing fascia. The attachments of the Parotid fascia include  
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Anteriorly Mandible 
 
Inferiorly Stylomandibular ligament 
 
Posteriorly Styloid process 
 
Vascular supply: 
It is supplied by the branches of the external carotid artery and drained by 
external jugular vein. 
Nerve supply: 
It is via the Auriculo-temporal nerve which is a branch of the 
mandibular branch of trigeminal nerve.  
The parasympathetic nerves are secreto-motor. The preganglionic 
fibres begin in the inferior salivary nucleus; pass through the IX nerve, its 
tympanic branch, the tympanic plexus and the lesser petrosal nerve and 
relay in the otic ganglion. The post ganglionic fibres pass through the 
auriculo-temporal nerve and the gland. 
Sympathetic nerves are vasomotor and are derived from the plexus 
around the external carotid artery. 
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Sensory nerves are from the auriculo-temporal nerve to the gland 
but the parotid fascia is innervated by the sensory fibres of the greater 
auricular nerve. 
Lymph nodes: The parotid nodes lie partly in the superficial fascia 
and partly deep to deep fascia over the parotid. This occurs as during 
development the parotid is the last to get encapsulated hence results in 
encapsulation of the nodes. Also during this process salivary epithelial 
cells can be included within the nodes and believed to play a role in 
development of Warthin’s tumor5. 
HISTOLOGY: 
The parotid gland is a predominantly serous salivary gland contains 
numerous serous acini. Also there are zymogen granules, intercalated and 
striated ducts. Small lymph nodes within the gland give rise to interstitial 
lymphocytes. Varying degrees of adipocytes are also seen depending 
upon the patient’s age. 
The parotid gland secretion is watery and is about 20% of the total 
secretion from salivary glands. 
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Fig.e)HISTOLOGY OF PAROTID GLAND 
PAROTID LESIONS: 
Non-neoplastic disorders of the parotid can be classified as 
follows
7, 17
: 
1. Inflammatory 
* Acute (specific) 
a. Viral (mumps, Coxsackie virus A, echovirus, and 
lymphocytic choriomeningitis) 
 
b. Bacterial (staphylococcal, streptococcal, 
pneumococcal, Gram-negative) 
Acute suppurative of infancy 
Postsurgical 
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Terminal debilitation 
* Chronic (specific) 
Tuberculosis 
Actinomycosis 
Sarcoidosis 
* 'Recurrent subacute' and chronic recurrent 
Self-limited 
Progressive 
Lymphoepithelial lesion and Sjogren's syndrome 
2. Systemic and Secondary Metabolic Disorders 
3. Obesity, hypertension, diabetes mellitus, malnutrition and 
associated deficiencies (proteins, vitamins), alcoholic liver disease 
Hypersensitivity and Drug idiosyncrasy 
Local (Salivary Gland) Disturbances 
Sialolithiasis 
Sialoangiectasis 
Trauma, foreign body, fistula 
Parotid lymphadenopathy 
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Cysts, mucocele and ranula 
Local duct obstructions (mucous plugs, congenital) 
4. Miscellaneous 
Pneumoparotitis 
Psychogenic 
Functional over activity 
Idiopathic 
Irradiation sialadenitis 
NON-NEOPLASTIC PAROTID LESIONS : 
1. Parotitis : 
These are seen to occur due to bacterial, viral causes or as a result 
of auto-immune disorders. Viral parotitis is the most common and caused 
by paramyxovirus. Other viral infections associated are Epstein-Barr 
virus, Coxsackie and parainfluenza virus. Bacterial  infections associated 
are Staphylococcus aureus and Streptococcus viridans. Bacterial 
infections lead to abscess formation. Antibiotics and if necessary incision 
and drainage are the mainstay of treatment in the above cases.  
 
Autoimmune disorders such as Sjögren's syndrome, rheumatoid 
arthritis and hypergammaglobulinemia. In early part of autoimmune 
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disorders lymphoplasmocytic infiltrate is seen with almost no 
parenchymal distortion. If a nodular collection > 50 lymphocytes (“ focus 
score”) is seen, the condition is said to be chronic sialadenitis20. Late in 
the disease, near complete absence of acini is noted along with minimal 
ducts and dense intra-epithelial lymphocytosis. These conditions can later 
on lead to lymphomas.  
 
2. Sialolithiasis 
This is seen less in the parotid gland in comparison to the sub-
mandibular gland. They result from the concretions that coalese within 
the duct system. It can secondarily lead to chronic sialadenitis. It is a 
painful condition associated with increased pain and swelling during meal 
times.  The stone if radio-opaque can be visualized in radiographs. 
Treatment involves removal of the stone and gland portion which is 
affected. 
 
3. Chronic Sialadenitis (Chronic Sclerosing Sialadenitis): 
It is usually a unilateral condition which occurs most commonly 
due to an obstructive sialolithiasis; other causes are radiotherapy or duct 
strictures. It is also called Kuttner’s Tumour and can clinically mimic a 
neoplasm. Histology will show dilated, secretion filled ducts with 
lymphoplasmocytic infiltrate with occasional germinal centre early in the 
disease. In late stages, fibrotic ducts surround the gland with acinar 
atrophy. Treatment is by surgical excision. 
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Fig.f) HISTOPATHOLOGY OF CHRONIC SIALADENITIS 
NEOPLASTIC DISORDERS: 
The parotid gland is known for the high preponderance of benign 
tumors such as pleomorphic adenoma which is the commonest lesion. 
WHO classification of parotid neoplasms.
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TABLE - 1 
WHO CLASSIFICATION OF PAROTID NEOPLASMS
9 
 
MALIGNANT  TUMOURS BENIGN TUMORS 
Acinic cell carcinoma Pleomorphic adenoma 
Mucoepidermoid carcinoma  Myoepithelioma 
Adenoid cystic carcinoma  Basal cell adenoma 
Polymorphous low-grade 
adenocarcinoma 
Warthin tumor 
Epithelial-myoepithelial carcinoma  Oncocytoma 
Clear cell carcinoma, not otherwise 
specified 
Canalicular adenoma 
Basal cell adenocarcinoma  Sebaceous adenoma 
Sebaceous carcinoma Lymphadenoma- sebaceous and non-
sebaceous 
Sebaceous lymphadenocarcinoma Ductal papillomas 
- Inverted ductal papilloma 
-Intra ductal papilloma 
Sialadenoma pappiliferum 
 
Cystadenocarcinoma  Cystadenoma 
Low-grade cribriform 
cystadenocarcinoma 
 
Mucinous adenocarcinoma  SOFT TISSUE TUMOURS 
Oncocytic carcinoma  Haemangioma 
Salivary duct carcinoma   
Adenocarcinoma, not otherwise 
specified  
HAEMATOLYMPHOID 
TUMOURS 
Myoepithelial carcinoma  Hodgkin lymphoma 
Carcinoma ex pleomorphic adenoma  Diffuse large B-cell lymphoma  
Extranodal marginal zone B-cell 
lymphoma 
Carcinosarcoma   
Metastasizing pleomorphic adenoma  SECONDARY TUMOURS 
Squamous cell carcinoma  
Small cell carcinoma   
Large cell carcinoma   
Lymphoepithelial carcinoma   
Sialoblastoma   
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The exact etiology of parotid lesions is unknown but several 
factors have been implicated including  environmental and genetic. Over 
time, certain risk factors and clarification of causes have been done 
Proof of cause and effect does not exist in any of these postulated 
associations, and the etiology of most salivary gland cancers cannot be 
determined 
ETIOLOGY OF NEOPLASTIC LESIONS: 
J.W. Eveson et al
9
 study on neoplastic lesions proposed the 
following causes.  
1. VIRUSES: 
Strong associations between lympho-epithelial carcinomas and 
Epstein - Barr virus (EBV) have been made
9
. 
2. RADIATION: 
Evidence to understand compelling links between ionizing 
radiation and parotid tumors have been studied. Follow-up on a long term 
basis of atomic bomb victims showed contributory evidence towards an 
increase in these tumors. Those undergoing therapeutic radiation for the 
head and neck tumors also have an increased risk.  
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3. OCCUPATION: 
Industrial workers such as those in rubber manufacturing and 
plumbing industry due to exposure to metal and nickel compounds are 
prone for parotid tumors. Also those individuals in the woodworking, 
automobile industries and employed in asbestos mining are prone for 
increased risk of parotid tumors.  
4. LIFE STYLE : 
Though no association has been found between alcohol 
consumption, a definite association is found between Warthin’s tumor 
and smoking. An increased level of risk has also been postulated in those 
with high cholesterol intake. 
5. HORMONES: 
Conflicting reports regarding associations of endogenous hormones 
in parotid tumors have been reported. Estrogen receptors were found in 
nearly 80% of normal glands in males and females. Estrogen receptors 
have been reported in a minority of cases of acinic cell carcinoma, 
mucoepidermoid carcinoma and salivary duct carcinoma, but not detected 
in adenoid cystic carcinoma
9
. Certain studies have also reported estrogen 
receptors in pleomorphic adenoma.  
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Progesterone receptors are noted with high levels of expression in 
recurrent pleomorphic adenoma. Among malignant lesion, they were seen 
acinic cell carcinoma, adenoid cystic carcinomas and mucoepidermoid 
carcinomas. 
Androgen receptors are present in 90% of salivary duct 
carcinomas. A recent study has also shown this immune-reactivity in 
carcinoma ex pleomorphic adenoma and basal cell adenocarcinoma and a 
fifth of cases in the study showed positivity in acinic cell carcinoma, 
mucoepidermoid carcinoma and adenoid cystic carcinoma.  
PAROTID TUMORS: 
BENIGN TUMORS: 
1. Pleomorphic Adenoma- 
It is also known as benign mixed tumor as originally said by 
Minssen in 1874 and comprises of multiple histologic components 
including myxoid, mucoid, chondroid and other elements, hence known 
for its heterogeneity. These comprise almost 80% of parotid neoplasms
9
. 
To distinguish from a malignant transformation, features such as cellular 
atypia, mitosis, perivascular and perineural invasion are relied upon.  
They are slow growing, painless tumors, arising in 90% of cases from the 
superficial lobe. These tumors are noted to have pseudopods and hence 
have a tendency to recur if only enucleated.  
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The epithelial component consists of ductal structures with an 
associated myoepithelial layer, but also may contain collections of 
myoepithelial cells that may be spindled, clear, plasmacytoid, or basaloid. 
The mesenchymal, or stromal, component is typically myxoid, hyaline, or 
chondroid 
Pleomorphic adenomas have been divided into a myxoid type 
(>80% mesenchymal-type tissue), cellular type (>80% epithelial-type 
tissue), and mixed or classic type (generally an equal mix of 
components)
20
. Treatment is surgical and superficial parotidectomy is 
done in most cases. Total parotidectomy is done for deep lobe 
involvement.    
 
Fig.g) MICROSCOPIC PICTURE OF PLEOMORPHIC 
ADENOMA 
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2. Warthin’s tumor: 
This is also known as papillary cystadenoma lymphomatosum. It is 
the second most common benign parotid neoplasm associated with a10% 
bilateral incidence, male predominance and multi-centricity. Also it is 
almost exclusively found in the parotid gland. As mentioned earlier the 
late encapsulation of the gland and lymphatic tissue trapping during 
development favours the formation this tumor. Another salient feature of 
this tumor is that it contains plenty  of mitochondrial rich oncocytes and 
hence presents as hot spots on radio nucleotide with Technetium 99M
21
. 
Microscopically what we see characteristically are two-tiered epithelial 
layer, lining the branching, cystic or cleft-like spaces and immediately 
subjacent, well-developed lymphoid tissue sometimes forming germinal 
centers
20
.  
 
Fig. h)MICROSCOPIC PICTURE OF WARTHIN'S TUMOUR 
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3. Basal cell adenoma: 
They are benign tumors basaloid cells. They tend to occur 
generally in adults with 75% occurring in the parotid gland. They are 
usually asymptomatic, slow growing lesions. A subtype called the dermal 
anlage tumor may be multicentric and may be associated with various 
adenexal skin tumors. Though four patterns are seen microscopically, the 
tumor is composed of 2 cell types. Small cells with little cytoplasm 
typically lie at the neoplasm's edge, frequently show peripheral 
palisading, and give the tumor its basaloid appearance. The other type 
being more polygonal basaloid cells with slightly more cytoplasm and 
round to oval nuclei containing more open chromatin usually lay in the 
tumor's center. They are immunopositive for pan-cytokeratin S-100, 
smooth muscle actin, and muscle-specific actin, all evidencing 
myoepithelial differentiation.  
4. Myoepithelioma : 
These are benign tumors which are almost exclusively composed 
of myoepithelial cells although a small percentage can be made up of 
ductal cells. Hence they are considered to lie at one of the spectrum with 
basal cell adenoma at the opposite end and pleomorphic adenoma more in 
the center
20
. It is seen to occur in almost equal frequency in the parotid 
gland and minor salivary glands. Histologically the lesion comprises of 
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sheets and cords of tumor cells. They are classified into four sub-types all 
of which have collagenous or myxoid stroma: 
I) Spindle-cell  II) Hyaline  III) Plasmatoid 
IV)  Clear cell  
Cells stain strongly positive for S-100 and cytokeratin and are 
variably reactive to smooth muscle actin and glial fibrillary acid protein 
(GFAP)
20
. 
MALIGNANT TUMORS: 
1. Mucoepidermoid carcinoma: 
It is the most common parotid malignancy, composed of mucous, 
intermediate, and epidermoid (or squamoid) cells. They are noted to be 
slightly more common in women with a mean incidence around the 5
th
 
decade of life
20
. Patients present with a slow growing, painless mass.  
Hallmark of these tumors is the presence of three different cell types 
which can occur in sheets, nests, duct like structures or cysts. Frequently 
intermediate cells predominate, ranging from small basal cells with 
minimal basophilic cytoplasm to larger oval cells with pale eosinophilic 
cytoplasm. The mucin-producing cells are organized singly or in clusters , 
with pale, foamy cytoplasm, distinct cell membranes, and eccentric small 
nuclei. They line cystic spaces and are positive with mucicarmine or PAS 
stains
20
. Abundant eosinophilic cytoplasm and vesicular nuclei are seen in 
epidermoid or squamoid cells. Immunohistochemistry is of little utility in 
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the diagnosis of mucoepidermoid carcinoma. Many mucoepidermoid 
carcinomas possess a t (11;19)(q21;p13) translocation
20
. Tumors that 
carry the rearrangement are associated with a better clinical outcome. 
Prognosis is highly dependent on the grade of the tumor. Low-grade 
lesions are markedly cystic, and have abundant well-differentiated 
mucous cells. High-grade lesions are more solid with squamous and 
intermediate cells predominating.   
Table - 2 
BRANDWEIN GRADING OF MUCOEPIDERMOID 
CARCINOMA
20
: 
 
PARAMETER        POINTS 
Cystic component<25%      2 
Tumor front invades in small 
Nests and islands       2 
Pronounced nuclear atypia     2 
Lymphatic and or vascular invasion        3 
Neural invasion       3 
Necrosis        3 
4+ mitosis/ 10 HPF      3 
Bony invasion       3 
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Table - 3 
GRADING OF MUCOEPIDERMOID CARCINOMA 
Grade Point score/mortality (%) 
Low (I) 0 
Intermediate (II) 2–3 
High (III) 4 or more 
 
Wide local resection has to be done for these tumors. Radiation can 
be used in cases of recurrence or for palliation in case of unresectable 
lesions. Prognosis depends upon the grade of the tumor, excellent for low 
grade (>90%) and poorer for high grade tumor (about 50%)
20
.  
 
 
Fig.i) MICROSCOPY OF MUCOEPIDERMOID TUMORS 
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2. ACINIC CELL CARCINOMA: 
It accounts for a total of 1%–3% of salivary gland tumors of which 
it’s most common location is the parotid. It is the second most common 
malignancy
20
. It presents as a slowly growing mass, can be occasionally 
painful. It is seen usually as a single, circumscribed, solid mass and can 
undergo cystic degeneration. Histological variability is seen. It can be 
solid or lobular, microcystic, papillary-cystic or follicular. Small tumors 
due to their well-differentiated state can be missed easily. The 
characteristic cell seen is the acinic cell, which has the appearance of a 
salivary acinar cell with abundant granular, basophilic cytoplasm and a 
small, round, eccentrically placed nucleus. With PAS staining 
cytoplasmic zymogen granules are seen. A mixture of architectural 
patterns is seen and characteristic dense lymphoid infiltrate is also seen. 
Due to lack of tumor infiltration at the tumor periphery it can be confused 
as benign. Differential diagnosis includes a normal parotid gland, 
oncocytoma, clear cell carcinoma, cystadenocarcinoma. Adequate 
resection is necessary as recurrence is seen in about one- third of cases. It 
is considered as a low-grade malignancy, but around 10%–15% 
metastasizes regionally to lymph nodes or in a distance to lungs and 
bones.  Survival rate is around 80% in 5 years
20
.  
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Fig.j) MICROSCOPIY OF ACINIC CELL CARCINOMA 
  
3. ADENOID CYSTIC CARCINOMA: 
Peak incidence of this tumour is seen in patients between 40 and 60 
years of age. It is slow growing and progressive in nature. Perineural 
invasion is characteristic to this disease and at times it can be the 
presenting symptom of the disease such as facial nerve palsy. Varying 
architectural patterns can be seen, cribriform, tubular, solid and mixed. 
Grading is based on the dominant pattern; most commonly seen is 
cribriform, consisting of cell nests arranged around gland-like spaces 
filled with PAS positive granular basophilic material. The spaces are 
actually extra-cellular cavities containing reduplicated basal lamina and 
myxoid material.  The tumor cells are basaloid with round to oval, 
hyperchromatic nuclei without nucleoli and very little cytoplasm.   
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Grading of Adenoid Cystic Carcinoma 
Predominant pattern Grade 
Tubular I 
Cribriform II 
Solid III 
 
 
Perineural invasion is common in the tumor periphery. 
Immunohistochemistry is of little use. Positive reaction for cytokeratins, 
collagen type IV and laminin and partial reactivity towards myoepithelial 
markers is seen.  This tumor is highly malignant and progressive.  
Compared to other cancers this has a lower survival rate of around 62% at 
five years
20
. Involvement of bone, perineural invasion and solid type of 
tumors show poorer prognosis.   
 
Fig.k) MICROSCOPIC PICTURE OF ADENOID CYSTIC 
CARCINOMA 
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4. MALIGNANT MIXED TUMORS: 
This term is broadly used to true malignant mixed tumors, 
carcinoma ex pleomorphic adenoma and metastatic mixed tumor
20
. 
 
I) True salivary gland mixed tumor( carcinosarcoma) 
 
This is composed of both carcinomatous and sarcomatous 
components and is extremely rare, About one third of patients have pre-
existing pleomorphic adenoma. It presents around the sixth decade and 
microscopically it is seen to have an intimate admixture of both 
components. High grade duct carcinoma or undifferentiated carcinoma 
mixed with fibrosarcoma, leiomyosarcoma or liposarcoma is seen
20
. 
These are extremely aggressive tumors treated with wide local excision n 
and radiotherapy. 
 
II) Carcinoma ex pleomorphic adenoma: 
These account for >95% of mixed malignant tumors. The classical 
history is a long standing parotid mass that has undergone rapid growth 
over few months. The risk of malignancy increases with the number of 
years the tumour is left untreated, 1.5% in 5 years and 9.5% in 10 years
21
. 
The proportions of carcinoma and pleomorphic adenoma can vary; the 
malignant component can be poorly differentiated adenocarcinoma, 
salivary ductal carcinoma or undifferentiated carcinoma. Prognosis is 
dependent upon the carcinoma type and extent of invasion. Invasion is 
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classified as intracapsular (noninvasive), minimally invasive (≤ 1.5mm in 
the greatest extent) or invasive (≥1.5mm in the greatest extent) 20. Wide 
resection with lymph node dissection in cases of nodal metastasis is done 
and radiotherapy provided postoperatively or for invasive and inoperable 
tumours. 
III) Metastasizing mixed tumor: 
This is the least common. Histologically they resemble 
pleomorphic adenoma but are associated with metastasis to local lymph 
nodes or distant organ metastasis.  
5. SALIVARY DUCT CARCINOMA: 
This is one of the most aggressive primary salivary gland tumors. 
This resembles high-grade ductal carcinoma of breast. Male are more 
commonly affected and clinically it seen as a rapidly growing parotid 
mass with skin and facial nerve involvement. These are well demarcated 
and partly encapsulated with invasion into adjacent parenchyma.  
Microscopy shows ductal structures lined by eosinophilic cells with 
supporting layer of clear myoepithelial cells with hyalinized, eosinophilic 
stroma between cells. Wide local excision and radiotherapy are the 
treatment modalities. 
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6. LYMPHOMA: 
It is extremely rare and can occur in < 5% of patients with parotid 
lesions. Suggestive clinical features are development of a parotid mass in 
a known patient of malignant lymphoma, or suffering from an immune 
disorder (Sjogren’s syndrome, rheumatoid arthritis or AIDS) or in an 
individual with a previous benign lymphoepithelial lesion. The prognosis 
is usually better than nodal lymphoma of same histology. 
A  
B  
Fig. l) LYMPHOMA OF PAROTID GLAND -A. MICROSCOPIC 
PICTURE B. CT PICTURE 
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7. METASTASIS TO PAROTID: 
As such the metastasis is more to the intra or periglandular lymph 
nodes and they are most commonly from the primary tumors of the head 
and neck. The parotid nodes provide the drainage basin from the scalp, 
face, ear skin, external auditory canal and tympanic membrane. Hence 
squamous cell carcinomas and melanomas account for around 80%. The 
remainder is most commonly from the lung, kidney and breast 
carcinomas.  
PHYSICAL EXAMINATION: 
The diagnosis depends upon essential findings in the history and 
physical examination. In the examination one should focus on the extent 
of disease in the parotid, neck, local effects of the lesion and nerve 
involvement.  The mass is palpated to determine presence of pain, its 
consistency, mobility and fixity to the adjacent tissue. The skin of scalp, 
face and ear is examined for lesions. Any evidence of neck node 
involvement is palpated for. Oral cavity is examined for the duct opening 
and deep lobe assessment. The pharyngeal wall is examined for deviation 
and jaw is examined for trismus. Findings suggestive of malignancy 
include a large, fixed mass, facial nerve weakness, nodal metastasis, skin 
involvement and at times trismus.  
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Fig.m) PAROTID GLAND TUMOUR 
          
Fig.n) PAROTID LESION SEEN IN THE TAIL REGION 
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STAGING OF PAROTID TUMORS 
TNM staging 
PRIMARY TUMOUR: 
TX Primary tumor cannot be assessed 
T0 No evidence of primary tumor 
T1 Tumor ≤2 cm in greatest dimension without extra parenchymal 
extension 
T2 Tumor >2 cm but not >4 cm in greatest dimension without extra 
parenchymal extension 
T3 Tumor >4 cm and/or tumor having extra parenchymal extension 
T4a Tumor invades skin, mandible, ear canal, and/or facial nerve 
T4b Tumor invades skull base and/or pterygoid plates and/or 
encases carotid artery 
REGIONAL LYMPH NODES (N) 
NX Regional lymph nodes cannot be assessed 
N0 No regional lymph node metastasis 
N1 Metastasis in a single ipsilateral lymph node, ≤3 cm in greatest 
dimension 
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N2a Metastasis in a single ipsilateral lymph node, >3 cm but not >6 
cm in greatest dimension 
N2b Metastasis in multiple ipsilateral lymph nodes, none more than 
6 cm in greatest dimension 
N2c Metastasis in bilateral or contralateral lymph nodes, none >6 cm 
in greatest dimension 
N3 Metastasis in a lymph node, >6 cm in greatest dimension 
DISTANT METASTASIS (M) 
MX Distant metastasis cannot be assessed 
M0 No distant metastasis 
M1 Distant metastasis 
Table 4: STAGE GROUPING- AJCC 
STAGE GROUPING 
Stage I T1 N0 M0 
Stage II T2 N0 M0 
Stage III T3 N0 M0 
Stage III T1 N1 M0 
Stage III T2 N1 M0 
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Stage III T3 N1 M0 
Stage IVA T4a N0 M0 
Stage IVA T4a N1 M0 
Stage IVA T1 N2 M0 
Stage IVA T2 N2 M0 
Stage IVA T3 N2 M0 
Stage IVA T4a N2 M0 
Stage IVB T4b Any N M0 
Stage IVB Any T N3 M0 
Stage IVC Any T Any N M1 
 
PROGNOSTIC FACTORS: 
1. Age at diagnosis  2. Pain at presentation  3. T stage  
4. N stage    5. Skin invasion   6. Facial nerve dysfunction 
7. Perineural growth  8. Positive surgical margins 
9. Soft tissue invasion 10. Treatment type 
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MANAGEMENT  
INVESTIGATIONS: 
FINE NEEDLE ASPIRATION: 
Cytological analysis which can be achieved through FNA is helpful 
in a pre-operative evaluation to distinguish between malignant and benign 
lesions. It is considered safe when done with 23 gauge needle. It can also 
be done with a 25 gauge needle
11.
 
Most commonly performed blindly in the outpatient clinic and has 
several advantages – it is quick, safe and accurate in the hands of a skilled 
practitioner and high levels of diagnostic accuracy. Accuracy increases 
when used under ultrasound guidance
12
. An average accuracy is estimated 
around 54% to98%. The diagnostic accuracy is less in cases of malignant 
lesions compared to benign ones. Sensitivity up to 70% and specificity 
around 94% can be obtained.  It can be useful to distinguish not only 
between benign and malignant tumor, but also salivary and non-salivary 
processes. It can be indicated to identify suspected malignancies, 
diagnose metastatic carcinomas, suspected lymphomas and evaluate 
bilateral tumors. Also it helps enable conservative management in 
Warthin’s tumour or pleomorphic adenomas in poor risk patients. A study 
by A.M. Contucci et al
26
 where the FNA  and final histopathology were 
compared showed sensitivity and specificity of 57.3% and 100% 
respectively with and overall diagnostic accuracy of 94%. 
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RADIOLOGICAL INVESTIGATIONS: 
1. SIALOGRAPHY: 
This helps in diagnosing lesions of the Stenson’s duct such as 
strictures, calculi. Also in the presence of any parotid enlargement the 
displacement of the duct can be seen. It is rarely used, both because there 
is a significant possibility of an infectious flare-up and because the study 
actually yields only minimal information. 
2. ULTRASOUND; 
It helps to distinguish between solid and cystic lesions and also to 
identify lymph nodes. An important application is when it is used in 
guided FNAC increases the accuracy of FNAC.  
 
 
 
 
 
Fig.o) ULTRASOUND OF PAROTID LESION- CYSTIC 
APPEARANCE 
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         A study published regarding ultrasound guided FNA showed that in 
74 out of 76 cases a cytological diagnosis was achieved
22
. 
3. CT 
CT is superior to MRI for evaluation of the bony structures. It is 
indicated in patients with diffuse enlargement of the parotid gland, tumor 
extension beyond the superficial lobe, facial nerve weakness, trismus, or 
deep-lobe parotid tumors that are difficult to evaluate clinically
10
. If the 
parotid mass appears to be fixed to the deeper structures, it is appropriate 
to proceed with CT to evaluate the extent and parapharyngeal extension 
of the disease. 
 
Fig.p)CT PICTURE OF PAROTID NEOPLASM 
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Fig.q)CT PICTURE OF ACUTE PAROTITIS 
MRI: 
MRI helps to distinguish inflammatory lesions from neoplasms of 
the parotid. It is indicated in cases of facial nerve palsy. It also is helpful 
in distinguishing deep lobe tumors from other parapharyngeal masses, 
evaluating suspicious lymph nodes and the periphery of the mass 
RADIONUCLEOTIDE TECHNITIUM 99M SCAN: 
This is seen to be helpful in identifying Warthin’s tumors and 
oncocytomas as hot spots that they present with due to the presence of 
oncocytes. They are not used presently as before. 
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Fig.r) RADIONUCLEOTIDE SCAN IN ONCOCYTOMA 
TREATMENT: 
Surgery is the primary treatment done for most of the parotid 
swelling presenting in a Surgical department. Other modalities which 
may be used are radiotherapy as an adjuvant or neo-adjuvant form. 
Chemotherapy is administered in cases of palliation or lymphomas. 
SURGICAL: 
Principles of treatment of parotid lesion
10
: 
1. Adequate local excision of tumor, based on extent of 
primary lesion and the primary lesion itself. 
2. Preservation of facial nerve if possible 
3. Elective neck dissection reserved for selected patients 
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4. 4.Postoperative radiotherapy when indicated (in appropriate 
fields) 
5. Prognosis determined primarily by stage and grade of tumor. 
The basic types of surgeries done for removal of the parotid gland 
are as follows: 
1. Superficial parotidectomy 
2. Total conservative parotidectomy 
3. Radical parotidectomy 
 
1. SUPERFICIAL PAROTIDECTOMY: 
It is the minimal surgical procedure for a parotid mass requiring 
removal involving the superficial lobe. Identification and dissection of the 
facial nerve is of extreme importance as otherwise inadvertent injury can 
occur. General anaesthesia without muscle relaxation should be 
advocated for this. Incision for the procedure should be planned keeping 
the adequate surgical exposure and cosmesis in mind. It begins anterior to 
the ear, just above the tragus, continuing downward past the tragus, 
curving behind the ear and turning downward to descend along the 
sternocleidomastoid.  The incision is deepened upto the subcutaneous 
level and a plane is developed between the external ear canal and the 
posterior aspect of the parotid. Anterior flap is created in a plane 
superficial to the parotid fascia. The sternomastoid muscle after 
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identifying its anterior border is retracted after dissecting the gland from 
it. The Greater auricular nerve may be sacrificed if required. Dissection 
should be continued along the plane and attachments to the mastoid be 
cut and the posterior belly of digastric muscle is identified. Dissection 
should be done in a vertical plane to minimize risk of injury to the distal 
branches of facial nerve
10
. At this point the identification of the facial 
nerve should be made as it emerges from the stylomastoid foramen. The 
nerve can be identifies by an antegrade or a retrograde approach.  In the 
antegrade approach the main trunk of the nerve is identified, usually 
located at a point which underlies the halfway point between mastoid 
process tip and ear canal. Other landmarks include tragal pointer, the 
posterior digastric belly and tympanomastoid suture. To ensure the safety 
of the nerve, several centimeters of the parotid need to be mobilized. At a 
proximity to the nerve electrocautery is best avoided. Retrograde 
approach is used when the main trunk cannot be exposed and hence 
dissection is proceeded from a peripheral branch to the main trunk. 
Alternatively nerve stimulator may be used to identify the branches. Once 
the nerve trunk has been identified and dissected all around carefully, 
sharp dissection is used to divide the gland substance while protecting the 
nerve. It is important that each division of the gland reveals more of the 
nerve. Once the dissection is done, all the branches of the nerve have 
been defined and the superficial part of the gland removed, after ensuring 
hemostasis the wound can be closed with a suction drain in situ. The 
patient is closely monitored for any facial nerve palsy. 
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2. TOTAL PAROTIDECTOMY 
This is employed in case of malignant lesions and lesions with 
deep lobe involvement. After proceeding as superficial parotidectomy the 
nerve trunks are gently retracted and excision of the deep lobe is done. In 
case there is retromandibular extension of the tumor, the incision can be 
extended anteriorly over the mentum and paramedian mandibulotomy can 
be performed. 
 
Fig. s) SPECIMEN OF TOTAL PAROTIDECTOMY 
3. RADICAL PAROTIDECTOMY: 
It is employed for patients with advanced parotid carcinomas. 
Facial nerve is sacrificed. Extended radical surgery involves resection of 
overlying skin, adjacent mandible and soft tissue, temporal bone and 
portion of the adjacent external ear. Free tissue transfer used for repair of 
facial nerve.  
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Fig.t) INTRA-OPERATIVE FACIAL NERVE IDENTIFICATION 
  
 
 
 
 
 
 
Fig. u) SPECIMEN OF EXTENDED RADICAL 
PAROTIDECTOMY 
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4. NECK DISSECTION: 
In patients which detectable neck nodes, high grade tumors and 
infiltrative tumors it is commonly performed. The decision to employ a 
radical, modified radical or functional neck dissection is made based on 
the grade of tumor and nodal involvement. 
SURGICAL COMPLICATIONS:   
Complications which occur due to parotidectomy are related to the 
meticulous dissection, the lesion and anatomy identification. The most 
commonly seen complication is facial nerve involvement, which could be 
temporary or permanent. Other complications such as Frey’s syndrome 
though inferred from previous studies found to be common, it is now seen 
that the incidence is actually much less than expected. A study
18
 
classified the complications based on the time of occurrence, into intra-
operative, early and late complications. The following possible 
complications can be seen:  
1. Facial nerve palsy: It may be transient of permanent. If the nerve 
transection is identified intra-operatively primary repair may be done 
either as a tension free anastomosis or interposition nerve grafts. An 
incidence ranging from 17% to 100% can occur as transient facial nerve 
paralysis depending upon the extent of resection and tumour location. 
10
. 
Permanent paralysis has been seen fortunately in less than 5% of cases. 
10
.  
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2. Gustatory sweating (Frey’s syndrome) : It occurs when there is 
cross-innervation of parasympathetic and sympathetic fibres which 
supply the parotid. On chewing food there is sweating, flushing and skin 
warmth. Symptomatic treatment alone is adequate in a majority of 
patients. Though there it has been extensively been written about, its 
general incidence is low, but varies with centres. Some have reported as 
high as 50%
18
.  Conservative management is usually advocated with 
application of topical anti-perspirants but surgeries such as superficial 
temporal artery fascial flap positioning are also done in severe cases. 
Newer modalities to treat this condition include botulinum toxin (BTX) 
injection.  
 
3. Salivary fistula: Also called sialocele it is usually self-limiting 
condition seen in 1%–15 % of parotidectomies10. Its attributed more to 
gland disruption than injury to Stenson’s duct. Conservative management 
with anti-cholinergics may be done, other than which at times completion 
parotidectomy and low dose radiation may be employed. Staffieri et al. 
first proposed, in 1999, BTX in the treatment of salivary fistula and 
sialoceles after conservative treatment failure 
19 
. 
 
4. Seroma 
 
5. Flap necrosis- it has been noted to occur at the distal tip of the 
posterior auricular flap.  
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6. Keloid formation 
7. Cosmetic deformity  
8. Hemorrhage 
9. Wound infection  
10.  Hypoaesthesia over Greater auricular nerve distribution 
 
 
Fig.v) FLAP NECROSIS SEEN ON 6TH POST-OPERATIVE DAY 
RADIOTHERAPY: 
Indications: 
1. Highly malignant, aggressive tumor 
2. Invasion of tissues adjacent to parotid capsule 
3. Regional lymph nodal metastasis 
4. Deep lobe cancers 
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5. Recurrent tumors 
6. Facial nerve infiltration by tumor. 
The minimal treatment volumes for the parotid lesions are the 
parotid bed and upper neck nodes. Tumour dose to the primary area is 
around 60 to 65 Gy in a period over 7 weeks. Higher dosage is used for 
microscopic positive margins or gross disease. 
Complications: 
1. Xerostomia     2. Tismus    3. Otitis media   4. Osteoradionecrosis  
5.hair loss 
CHEMOTHERAPY: 
Cisplatin, paclitaxel, vinorelbine, epirubicin and mitoxantrone have 
had good response in around 10%–20% of studies. But response is still 
limited and several trials are ongoing. Trials are also underway for 
targeted therapy.  
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AIM OF THE STUDY 
 
1. To study the incidence of various of parotid swellings in our 
institution. 
 
2. To discuss accuracy of FNAC in comparison to the histo-
pathological reports in our institution.  
 
3. To study the various surgical modalities of treatment of 
parotid swellings applied in our institution. 
 
4. To discuss the post-operative complications in our 
institution.   
 
5. To compare findings of the above study with world statistics.  
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MATERIALS AND METHODS 
The cohort study which included 45 patients was conducted at 
Kilpauk medical college hospital and Government Royapettah Hospital 
from September 2010 to October 2012. Data was collected from the 
patients after obtaining an informed consent. The study group consisted 
of 19 males and 26 female patients . The age group ranged from 16 years 
to 77 years. FNAC was performed in all patients. A total of 7 non-
neoplastic, 22 neoplastic and 16 malignant lesions were identified. Forty 
one patients were operated on and histopathology of specimens was done 
in 41 cases, which included 4 cases where only biopsy was performed. 
Postoperative radiotherapy was given in 10 cases while palliative 
radiotherapy was provided in 4 cases. One case underwent chemotherapy.  
Inclusion criteria : 
Patients with parotid swellings neoplastic and non-neoplastic  
Age of 12years and above. 
Exclusion criteria:  
Patients with parotid lesions due to systemic or metabolic illness.  
Age less than 12 years 
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OBSERVATION AND ANALYSIS 
The observation of the study of 45 parotid lesions yielded the 
following results: 
1. OVERALL  INCIDENCE  
LESION TOTAL NUMBER 
OF CASES 
PERCENTAGE 
Non- neoplastic 7 15.55% 
Benign 22 48.89% 
Malignant 16 35.56% 
 
 
 
 
 
 
 
 
 
 
 
OVERALL INCIDENCE OF LESIONS
15.55%
48.89%
35.56%
0
Non- neoplastic Lesions
Benign
Malignant
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2. SEX INCIDENCE DISTRIBUTION THE FOLLOWING 
 RESULTS WERE NOTED.  
 
 Male Female Total 
Non-neoplastic 4.44% 11.11% 15.55% 
Benign tumor 22.22% 26.67% 48.89%% 
Malignant 
tumour 
17.78% 17.78% 35.56% 
 
LESION AND SEX INCIDENCE
4.44%
26.67%
15.55%
48.89%
35.56%
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17.78%
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17.78%
0.00%
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50.00%
60.00%
Non-neoplastic Benign Malignant
MALE
FEMALE
OVERALL %
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3. AGE INCIDENCE: 
Age group No. of cases Percentage 
10-16 3 6.66% 
20-29 5 11.11% 
30-39 9 19.98% 
40-49 7 15.54% 
50-59 7 15.54% 
60-69 9 19.98% 
70-79 5 11.11% 
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4. FNAC  
FNAC has been discussed subsequently under the respective 
lesions.  
5. MANAGEMENT 
A. SURGICAL 
Superficial parotidectomy was the most commonly performed 
surgery. Total conservative parotidectomy was the second most common. 
TYPE OF SURGERY NO. OF CASES PERCENTAGE 
SUPERFICIAL 
PAROTIDECTOMY 
25 55.55% 
TOTAL 
PAROTIDECTOMY 
6 13.33% 
RADICAL 
PAROTIDECTOMY 
1 2.22% 
EXTENDED RADICAL 
PAROTIDECTOMY 
3 6.66% 
INCISION & 
DRAINAGE 
3 6.66% 
EXCISION 1 2.22% 
COMPLETION 
PAROTIDECTOMY 
2 4.44% 
 63 
B. NON-SURGICAL MODALITIES 
MODALITY 
RADIOTHERAPY CHEMOTHERAPY 
POST 
OPERATIVE 
PALLIATIVE  
NO. OF 
CASES 
10 4 1 
 
6. POST-OPERATIVE COMPLICATIONS: 
Complication Percentage 
Facial nerve palsy 20% 
Seroma 20% 
Flap Necrosis 4.44% 
Fistula 4.44% 
Others 2.22% 
 
Among the other complications it was seen that one patient had 
vocal cord paralysis. 
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Analysis of individual groups of lesions yielded the following 
results: 
1. NON- NEOPLASTIC LESION: 
The study of the lesions revealed the following results  
LESION MALE FEMALE 
Chronic Sialadenitis - 1 
Abscess 1 3 
Cystic lesion 1 - 
Reactive adenitis - 1 
 
INCIDENCE OF INDIVIDUAL NON-
NEOPLASTIC LESIONS 
14.28%
57.14%
14.28%
14.28%
Chronic sialdenitis
Abscess
Cystic lesion
Reactive adenitis
 
Abscess formed a majority of the non-neoplastic group with 4 out 
of 7 cases.  
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2. SEX INCIDENCE: 
SEX 
NO. OF 
CASES 
PERCENTAGE 
OVERALL 
PERCENTAGE(ALL 
LESIONS) 
MALE 2 28.57% 4.44% 
FEMALE 5 71.43% 11.11% 
 
MALE
FEMALE
28.57%
71.43%
0.00%
20.00%
40.00%
60.00%
80.00%
SEX INCIDENCE AMONG NON-NEOPLASTIC PAROTID LESIONS
 
 
Women were more affected by non-neoplastic parotid lesions than 
men having 71.43% of the lesions. 
 
3. FNAC 
In the cytological analysis it was noted that,  although there was a 
higher rate of lesions which were positive, the true positives were lesser. 
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Lesion Positive FNAC Accuracy 
Chronic sialadenitis 2 50% 
Abscess 5 100% 
Cystic lesion 2 50% 
Reactive adenitis 1 100% 
 
On further evaluvation of 3 lesions, they turned out to be Non-
Hodgkin’s lymphoma, mucoepidermoid carcinoma and pleomorphic 
adenoma. Hence the overall accuracy of FNAC is around 70%.  
In the data set of our study, it was found to be highly sensitive and 
highly specific. 
Positive predictive value of the  77% was  found with this data set. 
4. Age incidence: 
 
Age group No. of patients Percentage 
10-19 2 28.57% 
20-29 1 14.29% 
30-39 1 14.29% 
40-49 2 28.57% 
50-59 1 14.29% 
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AGE INCIDENCE FOR NON NEOPLASTIC LESION 
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5. Presentation:  
Presentation No. of patients Percentage 
Painful swelling 1 14.29% 
Painless swelling 6 85.71 
Discharge Nil - 
Facial nerve palsy Nil - 
Node enlargement Nil - 
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6. Treatment:  
TREATMENT PERCENTAGE 
OVERALL 
PERCENTAGE 
Incision and drainage 42.86% 6.66% 
Superficial parotidectomy 57.14% 8.88% 
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7. Complications:  
Significant complications noted in this was seen only in one case 
where seroma and parotid fistula developed. These resolved on its own 
with time and conservative medical management. 
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7. NEOPLASTIC LESIONS: 
A. BENIGN LESIONS: 
It was seen that among the benign lesions, pleomorphic adenoma 
was a dominant lesion. A total of 22 benign neoplasms were present in 
the study which comprised of 48.88% of all lesions in the study. 
1. Lesion incidence: 
Lesion No. of cases Percentage 
Overall 
percentage 
Pleomorphic adenoma 20 90.9% 44.44% 
Warthin’s tumor 1 4.55% 2.22% 
Lipoma 1 4.55% 2.22% 
 
INCIDENCES OF INDIVIDUAL BENIGN TUMOURS 
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2. Sex incidence:  
Sex No. of cases Percentage 
Overall 
percentage 
Male 10 45.45% 22.22% 
Female 12 54.55% 26.66% 
 
In this category it was seen that though the incidence was 
marginally more among females, males too were maximum affected by 
benign lesions. 
 
SEX INCIDENCE AMONG BENIGN LESIONS
0
45.45%
54.55%
0
MALE
FEMALES
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3.  AGE INCIDENCE: 
 
AGE 
GROUP(years) 
NO. OF 
PATIENTS 
PERCENTAGE 
% 
OVERALL 
PERCENTAGE 
(%) 
10-19 1 4.54% 2.22% 
20-29 2 9.09% 4.44% 
30-39 6 27.27% 13.33% 
40-49 4 18.16% 8.88% 
50-59 4 18.16% 8.88% 
60-69 4 18.16% 8.88% 
70-79 1 4.54% 2.22% 
 
 Therefore the age group most susceptible to benign tumours is in 
the 4
th
 decade. The youngest patient seen was a 16 year old male with a 
lipoma. 
AGE INCIDENCE FOR BENIGN TUMOURS 
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4. PRESENTATION: 
Presentation No. of cases Percentage 
Swelling without pain 21 46.66% 
Swelling with pain 1 2.22% 
Facial nerve palsy Nil  
Discharge Nil  
Deep lobe 
involvement 
Nil  
Recurrence 3 6.66% 
 
5. FNAC  
Lesion Total no. detected 
Pleomorphic adenoma 19 
Warthin’s tumor 1 
Lipoma 1 
 
 In one patient it the FNAC showed a cystic aspirate when it was 
actually a pleomorphic adenoma, therefore making the total number of 
pleomorphic adenoma to 20.  
 Sensitivity:     = 100% 
 Specificity       = 86.67% 
 Positive predictive value   =  93.75% 
 Negative predictive value  = 100% 
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6. TREATMENT: 
 Surgery was the mainstay treatment of the benign lesions. Most 
underwent superficial parotidectomy barring the case of lipoma who 
underwent excision of the lesion alone. 
 
Surgery No. of cases 
Percentage 
overall 
Percentage 
Superficial 
parotidectomy 
21 46.67 95.45 
Excision 1 2.22 4.55 
 
SURGERY FOR BENIGN PAROTID 
TUMOURS
0
95.45%
4.55%
Superficial parotidectomy
Excision
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7. POST- OPERATIVE COMPLICATIONS: 
 
Complication 
No. of 
patients 
Percentage of 
cases 
Seroma 4 18.18% 
Facial nerve palsy 1 4.54% 
Parotid fistula 1 4.54% 
 
POST OP COMPLICATIONS
18.18%
4.54%
4.54%
72.74%
SEROMA
FACIAL NERVE PALSY 
PAROTID FISTULA
NIL
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MALIGNANT LESIONS: 
 A total of 17 cases of malignant parotid tumors were there in our 
study, of which the predominant type seen was mucoepidermoid 
carcinoma comprising of 7 cases. 
1. Incidence  
Lesion 
No. of 
cases 
Percentage 
OVERALL % OF 
INCIDENCE 
Mucoepidermoid 
carcinoma- low grade 
4 23.54% 8.89% 
Mucoepidermoid 
carcinoma- high grade 
3 17.66% 6.67% 
Acinic cell carcinoma 1 5.88% 2.22% 
Adenoid cystic 
carcinoma 
2 11.76% 4.44% 
Carcinoma ex 
pleomorphic adenoma 
2 11.76% 4.44% 
Undifferentiated 1 5.88% 2.22% 
Lymphoma(NHL) 1 5.88% 2.22% 
Adenocarcinoma 2 11.76% 4.44% 
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INCIDENCE AMONGST MALIGNANT 
LESIONS
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1. SEX INCIDENCE: 
 
Sex 
No. of 
cases 
Percentage 
Overall 
percentage 
Male 8 50% 17.78% 
Female 8 50% 17.78% 
 
 It was seen that the malignancies of the parotid affected men and 
women with equal incidence. 
 
SEX INCIDENCE 
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1. AGE INCIDENCE: 
 
AGE(years) 
NO. OF 
CASES 
PERCENTAGE 
OVERALL 
PERCENTAGE 
10-19 NIL   
20-29 2 12.5% 4.44% 
30-39 2 12.5% 4.44% 
40-49 1 6.25% 2.22% 
50-59 2 12.5% 4.44% 
60-69 5 31.25% 11.1% 
70-79 4 25% 8.88% 
 
 The maximum incidence of malignancies was noted too be in the 
7
th
 decade seen in 31.25% of malignancies closely followed by the 8
th
 
decade affected in 25%. 
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AGE INCIDENCE FOR MALIGNANT TUMOURS 
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4. Presentation  
Presentation No. of cases Percentage 
Overall 
percentage 
Swelling with 
pain 
4 25% 8.88% 
Painless swelling 12 75% 26.67% 
Facial nerve 
palsy 
6 37.5% 13.33% 
Nodes 8 50% 17.78% 
Skin 4 25% 8.89% 
Deep lobe 
involvement 
2 12.5% 4.44% 
Discharge 1 6.25 2.22% 
Recurrence 6 37.5% 13.33% 
Mobility 
restricted 
5 31.25% 11.11% 
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 It was noted that half the cases of malignant parotid tumours 
presented with enlarged cervical nodes and a significant number of cases 
(37.5%) had associated facial nerve palsy.  
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 FNAC  
LESION Total no. Of 
positives 
Mucoepidermoid carcinoma 6 
Acinic cell carcinoma 3 
Adenoid cystic carcinoma nil 
Adenocarcinoma nil 
Carcinoma pleomorphic adenoma 2 
Malignant cells 3 
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  With FNAC it was seen that 14 malignant tumors were detected. 
The final histopathology report showed that a total of 16 malignant 
parotid lesions were present.  
It was seen that there were several errors in the detection of 
malignant lesions, not only regarding the type of lesion that was detected 
but in fact many were concluding a wrong result 
Sensitivity      = 87.5% 
Specificity      = 100% 
Positive predictive value   = 100% 
Negative predictive value  = 93.55% 
2. TREATMENT MODALITIES:  
Surgical modality was the mainstay treatment for most cases and 
the most commonly performed surgery was total parotidectomy, it 
comprised around 37.5%. Also neck dissection was performed in 31.5% 
of the cases.  
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Surgery No. of cases Percentage 
Overall 
percentage 
Total conservative 
parotidectomy 
6 37.5% 13.33% 
Radical 
parotidectomy(including 
extended radical 
parotidectomy) 
4 25% 8.89% 
Completion 
parotidectomy 
2 12.5% 4.44% 
Neck dissection 5 31.25% 11.11% 
Non-surgical 
management 
4 25% 8.89% 
 
Other modalities 
Radiotherapy was used in almost all cases, either in the form of 
palliation or post-operatively as an adjuvant. Adjuvant radiotherapy was 
given in 62.5% of the cases of malignancies and as palliation in 31.25% 
of cases. Chemotherapy was given as an adjuvant in one case where the 
diagnosis was Non-Hodgkin’s lymphoma (CHOP Regimen) and as 
palliation 1 case.  
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TREATMENT OF PAROTID MALIGNACIES
37.50%
25%
12.50%
25%
25% TOTAL PAROTIDECTOMY
RADICAL PAROTIDECTOMY
COMPLETION
PAROTIDECTOMY
NON-SURGICAL
NECK DISSECTION
 
3. POST-OPERATIVE COMPLICATIONS: 
The most common post-operative complication noted in this group 
of patients was facial palsy due to injury to the facial nerve, seen in 50% 
of the cases.  Also seroma formation was noted in 31.25% of the patients 
who underwent surgery. One patient had vocal cord palsy, due to the 
extensive dissection and resection of the infiltrative tumour.  
COMPLICATION 
NO. OF 
CASES 
PERCENTAGE 
OVERALL 
PERCENTAGE 
VII nerve palsy 8 50% 17.78% 
Seroma 5 31.25% 11.11% 
Flap necrosis 2 12.5% 4.44% 
Vocal cord palsy 1 6.25% 2.22% 
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DISCUSSION 
The comparative analysis of the study was made with other 
published studies and the following results were obtained. 
1. COMPARISON OF SEX INCIDENCE BETWEEN OUR 
INSTITUTION AND VARIOUS CENTRES: 
Institution KMC 
M D Anderson 
cancer center
8
 
Shaw Tsai et 
al
6
 
 
Male:female 1:1.25 1.02: 1 1.03:1 
Male 20 77 53 
Female 25 75 55 
 
1
1.25
1.02 11.03 1
0
0.2
0.4
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1.2
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KMCH
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Shaw Tsai et al
 
Our centre showed a slightly higher incidence among females in 
comparison to other centres.  
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1. FNAC COMPARISON BETWEEN OUR INSTITUTION AND 
 VARIOUS CENTRES 
CENTRE KMC 
M D ANDERSON 
CANCER CENTRE
8
 
Italy, picconi 
et al
14
 
SPECIFICITY 93.75% 86% 99% 
SENSITIVITY 93.33% 82% 81% 
PPV 96.87% 85% 93% 
NPV 96.77% 86% 98% 
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2. Incidence of various lesions among institutes: 
Centre 
NON-
NEOPLASTI
C LESIONS 
BENIGN 
TUMORS 
MALIGNANT 
TUMORS 
KMCH 15.55% 48.89% 35.56% 
M D ANDERSON
8
 7.14% 43.51% 49.35% 
Shaw Tsai et al
6
 13.89% 77.81% 8.3% 
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It was seen that among all the centers results for most common 
benign and malignant lesions were corresponding with each other, with 
pleomorphic adenoma and mucoepidermoid carcinoma respectively. 
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LESION BENIGN LESION MALIGNANT TUMOR 
KMCH PLEOMORPHIC 
ADENOMA (44.44%) 
MUCOEPIDERMOID 
CARCINOMA (6.67%) 
MD 
ANDERSON
8
 
PLEOMORPHIC 
ADENOMA (24.68%) 
MUCOEPIDERMOID 
CARCINOMA (5.19%) 
L.O. Piccioni 
et al 
14
 
PLEOMORPHIC 
ADENOMA(57.85%) 
MUCOEPIDERMOID 
CARCINOMA(2.85%) 
 
INCIDENCE OF PLEOMORPHIC ADENOMA AND MUCO-
EPIDERMOID CARCINOMA AMONG THE INSTITUTES 
KM
CH
M
 D
 A
ND
ER
SO
N
L.O
 P
IC
CI
PN
I e
t a
l
PLEOMORPHIC
ADENOMA
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
PLEOMORPHIC ADENOMA
MUCOEPIDERMOID CARCINOMA
 
 
 
 89 
3. SURGICAL MANAGEMENT: 
 
Superficial 
parotidectomy 
Total 
conservative 
parotidectom
y 
Total  
parotidetom
y with facial 
nerve 
resection 
Radical 
parotide
ctomy 
Neck 
dissection 
Others 
KMCH 53.33% 13.33%  8.89% 11.11% 13.33% 
Nagarkar et 
al
24
 
79.17% 12.5%  4.17% 4.17% 4.16% 
Acar A, et 
al
25
 
74.4% 16.28% 6.98% - 13.95% 2.32% 
 
In our study it was found that the other surgeries performed were 
completion parotidectomy, incision drainage and excision biopsies which 
corresponded with other studies. 
SURGICAL  MANAGEMENT AT VARIOUS CENTRES 
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OTHER TREATMENT MODALITIES: 
Radiotherapy was used as a postoperative adjuvant management in 
most cases of malignant tumors. 
 POST OPERATIVE 
RADIOTHERAPY 
KMCH 62.5% 
Acar A et al
25
 84.4% 
Nagarkar et al
24
 20% 
 
4. Postoperative complications 
Most common complication of surgery was noted to be facial nerve 
palsy, transient or permanent. 
POSTOP 
COMPLICATION 
FACIAL 
NERVE 
PALSY 
SEROMA/ 
HEMATOMA 
FLAP 
NECROSIS/ 
INFECTION 
PAROTID 
FISTULA 
KMCH 20% 20% 4.44% 4.44% 
Acar A et al 
25
 30.1% 5.8% 4.6% 3.4% 
Nagarkar et al
24
 29.17% - - 8.33% 
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CONCLUSION 
The analysis of the data of the study conducted at our institution 
provided us with the following results: 
1. Parotid lesions comprised of the most common salivary gland lesions 
in our hospital. 
2. Amongst the various lesions it was noted that benign tumours were 
the most common and the least common were non-neoplastic 
disorders. 
3. The sex incidence showed a similar distribution among both males 
and females with the ratio being 1:1.25. 
4. The mean age of presentation was 49 yearsand it was seen that the 
4th and 7
th
 decades where the predominant age group for occurrence 
in case of benign and malignant tumours respectively. 
5. The lesions which were predominant in the non-neoplastic, benign 
and malignant tumours groups where abscess, pleomorphic adenoma 
and mucoepidermoid carcinomas respectively. These were found to 
be consistent with the comparison made with world statistics.  
6. FNAC correlated in a total of 39 out of 45 cases, i.e.86.67% of the 
cases. 
 The sensitivity and specificity for detection of benign tumors was 
found to be 93.75% and 100% respectively. In the case of malignant 
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tumours the sensitivity and specificity was found to be 87.5% and 100% 
respectively.  
 
8. Patients presenting with facial nerve palsy was seen more amid the 
malignant tumors. 
9. Most commonly performed surgery was superficial parotidectomy. 
Completion parotidectomy was performed in 2 cases and both were 
malignant tumors with recurrence. 
10. Facial nerve palsy and seroma formation were the commonest 
complication noted post-operatively.  
11. Radiotherapy was the most common non-surgical modality used 
and administered more commonly post-operatively. 
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PROFORMA 
NAME     AGE & SEX   IP No. 
 
OCCUPATION    SOCIO-ECONOMIC STATUS 
ADDRESS 
HISTORY 
PRESENTING HISTORY: 
SWELLING  DURATION  DISCHARGE  PAIN 
SYMPTOMS OF FACIAL NERVE INVOLVEMENT 
OTHER 
PAST: 
EXPOSURE TO RADIATION TREATMENT FOR SIMILAR LESION 
PERSONAL  
ALCOHOL SMOKING TOBACCO/ BETEL NUT CHEWING 
EXAMINATION: 
GENERAL EXAMINATION : 
BUILD & NUTRITION  
ANAEMIA CLUBBING LYMPH NODE ENLARGEMENT 
LOCAL EXAMINATION: 
NUMBER SITE  SIZE     SHAPE SKIN  SURFACE 
INDURATION 
WARMTH TENDERNESS CONSISTENCY MOBILITY   
BI-DIGITAL PALPATION 
FACIAL NERVE INVOLVEMENT  
REGIONAL LYMPH NODE ENLARGEMENT 
INVESTIGATIONS: 
FNAC REPORT 
BLOOD INVESTIGATIONS :  Hb%  ESR  TC & DC 
RADIOLOGICAL:   
USG SWELLING     
CT HEAD AND NECK 
TREATMENT 
SURGERY  
OTHER MODALITY USED 
POST – OPERATIVE COMPLICATIONS IF ANY AND MANGEMENT 
HISTO-PATHOLOGICAL REPORT: 
Name
Age & 
Sex IP No. Prev Sx Side Size Past History Habits Duration
VII Nerve 
Involvement Mobility
Discharg
e Skin Nodes Pain
Deep 
Lobe FNAC HPE Surgery Other Findings Other Rx
P.O. 
Complications
Jayaeshwari 55/F 232 no left 6x5cm nil nil 3 years nil mobile nil free
level IB,II, 
III, IV,V nil nil ChSA NHL
Lt. RP + 
RND muscle 
infiltration
CHOP 
Regimen left VC plasy
Palaniammal 38/F 289 no left 4x5cm nil
tobacco 
chewing 3 months nil mobile nil free nil nil nil MEC MEC- LG Lt TCP nil nil seroma
Mahalakshmi 48/F 258 no left 3x3cm nil nil 1 year nil mobile nil free level II nil nil RA RA Lt SP nil nil nil
Karthiga 21/F 269 yes left 4x3cm
prev 
swelling+ nil 6 months nil fixed nil
 scar +, 
skin 
scarred level II nil involved ACCA AdCA
Lt 
ERP+Level 
II ND
facial nerve trunk 
encased P.O. RT VII N
Palaniammal 60/f 303 yes right 4x5cm
parotid 
abcess 
drainage-
15yrs ago
tobacco 
chewing 3 months nil mobile nil free nil yes involved
positive for 
malignancy U.CA Lt. ERP
musccle 
infiltration+, 
zygomatico-
temporal P.O. RT VII N
Meenambal 75/F 52 no left 4X6cm nil
tobacco 
chewing 6months nil fixed nil involved
Level 
II,III,IV,V yes nil s/o malignancy Ad.CCA
Lt. TCP Lt. 
RND
muscle 
infiltration P.O. RT VII N
Ramasamy 62/M 652 yes right 5x7cm
prev 
swelling+ smoking 8months nil mobile nil involved level II nil nil CXPA MPA Rt TCP
infiltration to 
muscle, , all 
margins +ve P.O. RT
seroma, flap 
necrosis
Jayalakshmi 50/F 602 yes right 4x5cm
prev 
swelling+ nil 1 year yes mobile nil free nil nil nil ACCA MEC- LG Rt CP
margins free, 
node-reactive 
hyperplasia P.O. RT
seroma, facial 
palsy
Munusamy 72/M 386 no right 6x7cm nil nil 1 month yes nil yes ulceration
level IB,IA, 
III nil nil
acute 
supurative 
inflammation MEC- LG Nil P.RT nil
Vasantha 65/F 1418 no left 7x7cm nil nil 1 1/2 years yes nil nil fixed level IB,II, yes nil MEC AdCA
Lt. ERP+ 
Lt. RND
muscle 
infiltration, 
arterial 
encasement P.O. RT
Facial nerve 
palsy
Ramasamy 70/M 55 no left 8x6cm nil
tobacco 
chewing 1 year yes fixed nil free nil nil nil
s/o malignancy- 
probably 
mucoepidermo
id Ca MEC- HG nil nil P.RT nil
Citi Babu 64/M 1231 yes right 5x3cm nil nil 8months nil nil nil scar nil nil nil ACCA
cystic 
neoplasm of 
parotid Rt. CP nil P.O. RT nil
Guna Sundari 26/F 1327 yes right 5x2cm nil nil 7yrs nil mobile nil NIL level II nil nil MEC MEC-LG Rt TCP
lower facial 
nerve trunk 
involved P.O. RT
Facial nerve 
palsy
Ravi 45/M 1240 no right 12x7cm nil smoking 6months nil fixed nil free nil yes nil CXPA CXPA nil P.RT
Facial nerve 
palsy
Durga Devi 17/F 18419 no right 5x4cm nil nil 1week nil mobile nil NIL nil yes nil  abscess Rt. I&D nil nil nil
Kanagavalli 37/F 14375 no left 6x4cm nil nil 10 days nil mobile nil nil nil yes nil  abscess Rt. I&D nil nil nil
Jayalakshmi 39/F 12797 yes right 6x5cm nil nil 1 1/2 years nil mobile nil nil nil nil nil PA PA Rt. SP nil nil nil
Dhayalan 63/M 9176 no right 6x7cm nil nil 10months nil mobile nil nil nil nil nil MEC MEC-HG
Rt. 
TCP+RND nil P.O. RT
seroma, flap 
necrosis
Jayalakshmi 39/F 11147 no right 5x6cm nil nil 1 year yes mobile NIL NIL nil nil nil ACCA ACCA Rt TCP nil P.O. RT
seroma, facial 
palsy
Arun Kumar 16/M 11952 no left 3x4cm nil nil 6months nil mobile nil NIL nil nil nil lipoma lipoma Lt. Ebx nil nil nil
Saroja 35/F 13343 no left 2x2cm nil nil 1year nil mobile nil NIL nil yes nil PA PA Lt. SP nil nil nil
Deepa 16/F 20123 no left 3x4cm nil nil 10days nil nil nil nil nil yes nil abscess Lt. I&D nil nil nil
Mosaraj Rathinam 54/M 18678 no right 5x6cm nil smoking 3 months nil mobile nil nil nil yes nil abscess
chronic 
abscess Rt.SP nil nil nil
Appandu 65/M 24950 yes right 6x7cm nil nil 3 months nil mobile nil scar+ nil nil nil PA PA Rt.SP nil nil nil
Matheena Beevi 63/F 17580 no right 6x4cm nil nil 7 months nil mobile nil NIL nil nil nil PA PA Rt.SP nil nil
Facial nerve 
palsy
Mohideen 50/ M 25629 no left 8x6cm nil smoking 2 years nil mobile nil nil nil nil nil WT WT Rt.SP nil nil seroma
Govindaraj 42/M 23032 no right 5x4cm nil nil 9months nil mobile nil nil nil nil nil PA PA Rt.SP nil nil nil
Rajagopal 57/M 1576 no left 6x5cm nil nil 6months nil mobile nil NIL nil nil nil PA PA Lt.SP nil nil nil
Chinnamal 55/F 1657 no left 6x4cm nil nil 1 year nil mobile nil NIL nil nil nil PA PA Lt.SP nil nil nil
Satya 35F 12697 no right 5x4cm nil nil 8 months nil mobile nil nil nil nil nil PA PA Rt.SP nil nil nil
Haridas 42/M 24561 no right 4x3cm nil nil 7 months nil mobile nil NIL nil nil nil cystic aspirate parotid cyst Rt.SP nil nil
seroma, parotid 
fistula
Malliga 34/F 3568 no left 3x4cm nil nil 6 months nil mobile nil nil nil nil nil PA PA Lt.SP nil nil parotid fistula
thirunavukarasu 70/M 13321 no right 6x4cm nil nil 8 months yes fixed nil fixed
Level 
II,III,IV nil nil MEC MEC-HG nil P.RT nil
Elumalai 29/M 1987 no right 3x4cm nil smoking 6 months nil mobile nil NIL nil nil nil PA PA Rt.SP nil nil nil
Velammal 60/F 15667 no left 5x6cm nil nil 1 year nil mobile nil NIL nil nil nil PA PA Lt.SP nil nil nil
Devaki 32/F 11451 no right 4x3cm nil nil 5months nil mobile nil NIL nil nil nil PA PA Rt.SP nil nil seroma
Dhanapal 49/M 12891 no right 5x3cm nil nil 7 months nil mobile nil NIL nil nil nil PA PA Rt.SP nil nil nil
Amutha 28/F 23013 no left 4x3cm nil nil 8 months nil mobile nil NIL nil nil nil PA PA Lt.SP nil nil nil
Janaki Raman 33/M 30012 no right 6x4cm nil nil 1 1/2 years nil mobile nil NIL nil nil nil PA PA Rt.SP nil nil nil
Jayanthi 47/F 23971 yes left 4x3cm nil nil 6 months nil mobile nil scar + nil nil nil PA PA Lt.SP nil nil seroma
Chellamai 52/F 1784 no left 5x4cm nil nil 9months nil mobile nil NIL nil nil nil PA PA Lt.SP nil nil nil
Kumar 41/M 16671 no right 3x4cm nil nil 6 months nil mobile nil NIL nil nil nil cystic aspirate PA Lt.SP nil nil seroma
Kamala 65/F 3224 no right 5x4cm nil
tobacco 
chewing 1 year nil mobile nil NIL nil nil nil PA PA Rt.SP nil nil nil
Kodeshwari 50/F 5030 no right 4x3cm nil nil 1 1/2 years nil mobile nil NIL nil yes nil C.SA C.SA Rt.SP nil nil nil
Bahadur 77/M 3903 no right 6x5cm nil nil 1 year nil mobile nil NIL nil nil nil PA PA Rt.SP nil nil nil
KEY TO MASTER CHART 
 CSA  - Chronic Sialadenitis  
 MEC  - Mucoepidermoid Carcinoma 
 PA  - Pleomorphic Adenoma 
 RA  - Reactive adenitis 
 ACCA - Acinic cell tumor Carcinoma 
 Ad. CA - Adenoid cystic Carcinoma 
 UCA  - Undifferentiated carcinoma 
 CxPA  - Carcinoma ex pleomorphic adenoma 
 WT  - Warthin’s tumour 
 Inf  - Inflammatory 
 PRT  - Palliative RT 
 PORT  - Postoperative RT 
 RP  - Radical parotidectomy 
 TCP  - Total conservative parotidectomy 
 SP  - Superficial parotidectomy 
 ERP  - Extended radical parotidectomy 
 CP  - Completion parotidectomy 
 I&D  - Incision and drainage 
 RND  - Radical Neck Dissection  
 
